Showing 1 - 7 results of 7 for search 'Matteo D'Addona', query time: 0.03s Refine Results
  1. 1
    Kaposi’s sarcoma associated with chronic myeloid leukemia and imatinib mesylate therapy

    Kaposi’s sarcoma associated with chronic myeloid leukemia and imatinib mesylate therapy by Matteo D’Addona, Luca Pezzullo, Valentina Giudice, Bianca Serio, Carlo Baldi, Pio Zeppa, Carmine Selleri

    Published 2022-06-01
    Get full text
    Article
  2. 2
    Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma

    Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma by Valentina Giudice, Luca Pezzullo, Giuseppe Ciancia, Matteo D'Addona, Francesca D'Alto, Marisa Gorrese, Bianca Cuffa, Carmine Selleri

    Published 2022-04-01
    Get full text
    Article
  3. 3
    A rare immune-related mesenteric and retroperitoneal serositis in a multirefractory Hodgkin lymphoma patient successfully treated with chylolymphostatic surgery

    A rare immune-related mesenteric and retroperitoneal serositis in a multirefractory Hodgkin lymphoma patient successfully treated with chylolymphostatic surgery by Matteo D'Addona, Luca Pezzullo, Corradino Campisi, Corrado Cesare Campisi, Valentina Giudice, Vincenzo Ciccone, Roberto Guariglia, Bianca Serio, Carmine Selleri

    Published 2023-10-01
    Get full text
    Article
  4. 4
    P1544: IMPACT OF SARS-COV 2 INFECTION, IN TREATED NHL-B AND HD, AFTER VACCINATION AND PREVENTIVE THERAPY WITH ANTIBODIES: OUR EXPERIENCE

    P1544: IMPACT OF SARS-COV 2 INFECTION, IN TREATED NHL-B AND HD, AFTER VACCINATION AND PREVENTIVE THERAPY WITH ANTIBODIES: OUR EXPERIENCE by Luca Pezzullo, Valentina Giudice, Matteo D’addona, Danilo DE Novellis, Idalucia Ferrara, Raffaele Fontana, Roberto Guariglia, Serena Luponio, Maria Carmela Martorelli, Laura Mettivier, Bianca Serio, Carmine Selleri

    Published 2023-08-01
    Get full text
    Article
  5. 5
    P1531: TIXAGEVIMAB-CILGAVIMAB THERAPY IN THE PREVENTION OF SARS-COV2 INFECTION IN NON-HODGKIN-B LYMPHOMAS AND HODGKIN LYMPHOMAS UNDER TREATMENT: OUR EXPERIENCE

    P1531: TIXAGEVIMAB-CILGAVIMAB THERAPY IN THE PREVENTION OF SARS-COV2 INFECTION IN NON-HODGKIN-B LYMPHOMAS AND HODGKIN LYMPHOMAS UNDER TREATMENT: OUR EXPERIENCE by Luca Pezzullo, Valentina Giudice, Matteo D’addona, Maria Teresa Buonanno, Danilo DE Novellis, Idalucia Ferrara, Raffaele Fontana, Roberto Guariglia, Serena Luponio, Maria Carmela Martorelli, Laura Mettivier, Bianca Serio, Carmine Selleri

    Published 2023-08-01
    Get full text
    Article
  6. 6
    Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study

    Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study by Danilo De Novellis, Raffaele Fontana, Angela Carobene, Bianca Serio, Idalucia Ferrara, Maria Carmen Martorelli, Laura Mettivier, Roberto Guariglia, Serena Luponio, Immacolata Ruggiero, Matteo D’Addona, Tiziana Di Leo, Valentina Giudice, Carmine Selleri

    Published 2022-07-01
    Get full text
    Article
  7. 7
    Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience

    Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Hap... by Bianca Serio, Gabriella Storti, Matteo D’Addona, Lidia Santoro, Camilla Frieri, Danilo De Novellis, Luana Marano, Giovanna De Santis, Roberto Guariglia, Ilenia Manfra, Eleonora Urciuoli, Serena Luponio, Serena Marotta, Denise Morini, Michela Rizzo, Fausto Palmieri, Nicola Cantore, Valentina Giudice, Antonio Maria Risitano, Carmine Selleri

    Published 2024-04-01
    Get full text
    Article

Search Tools: